ASCENDIS PHARMA A S's ticker is and the CUSIP is 04351P901. A total of 4 filers reported holding ASCENDIS PHARMA A S in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,341,000 | -73.8% | 25,000 | -75.0% | 0.00% | -100.0% |
| Q2 2023 | $8,925,000 | +11.0% | 100,000 | +33.3% | 0.00% | 0.0% |
| Q1 2023 | $8,042,000 | +2184.7% | 75,000 | +2400.0% | 0.00% | – |
| Q1 2022 | $352,000 | -92.2% | 3,000 | -88.9% | 0.00% | -100.0% |
| Q4 2020 | $4,503,000 | -10.1% | 27,000 | -25.0% | 0.00% | 0.0% |
| Q4 2019 | $5,008,000 | – | 36,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 54,800 | $5,875,656 | 0.02% |
| SIMPLEX TRADING, LLC | 60,000 | $6,433 | 0.01% |
| JANE STREET GROUP, LLC | 40,700 | $4,363,854 | 0.00% |
| JPMORGAN CHASE & CO | 75,000 | $8,042,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |